CLINICAL_TRIALS trial_result · 2024-03-26

Clinical Trial Update: A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) [Phase 3]

Phase 3 trial evaluating REL-1017 as adjunctive therapy for major depressive disorder; results and safety data were posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Relmada Therapeutics, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2024-03-26